Dorthe Sandager Bilde

Dorthe Sandager Bilde has a diverse work experience spanning across multiple companies. Dorthe Sandager began their career as a QA Chemist at Novo Nordisk A/S in 2003, where they were responsible for the release of bulk products and handling of deviations and change requests. Dorthe Sandager then worked as a Research Scientist at LEO Pharma A/S from 2004 to 2006.

In 2006, Dorthe joined CMC Biologics A/S as a Scientist, focusing on the downstream development and purification of proteins and MAb's. Dorthe Sandager then became a Manager in 2008, where they managed the daily operations and development of the department. As a Principal Scientist from 2010 to 2013, they were responsible for process characterization and group coordination.

Following their tenure at CMC Biologics, Dorthe joined ALK Abelló in 2013 as a Project Chemist, where they worked until 2015.

Dorthe Sandager then joined Biogen in 2015, initially as a Program Manager in Tech transfer, and later as a Senior Associate II in Compliance, specifically in large-scale manufacturing.

In 2016, Dorthe joined Symphogen as a Senior Scientist and later transitioned to the role of CMC Project Director in 2017, where they currently work.

Dorthe Sandager Bilde's education history begins in 1992 when they attended Skanderborg Amtsgymnasium, although the degree and field of study for this period are not provided. From 1996 to 2002, they pursued a M.Sc in Chemical Engineering at DTU - Technical University of Denmark.